154 related articles for article (PubMed ID: 36273427)
1. Inhibition of intermittent calcium-activated potassium channel (SK4) attenuates Ang II-induced hypertrophy of human-induced stem cell-derived cardiomyocytes via targeting Ras-Raf-MEK1/2-ERK1/2 and CN-NFAT signaling pathways.
Zhao H; Wang X; Tang Y; Zhao Q; Huang C
Cell Biol Int; 2023 Feb; 47(2):480-491. PubMed ID: 36273427
[TBL] [Abstract][Full Text] [Related]
2. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
[TBL] [Abstract][Full Text] [Related]
3. Lercanidipine attenuates angiotensin II-induced cardiomyocyte hypertrophy by blocking calcineurin-NFAT3 and CaMKII-HDAC4 signaling.
Chen Y; Yuan J; Jiang G; Zhu J; Zou Y; Lv Q
Mol Med Rep; 2017 Oct; 16(4):4545-4552. PubMed ID: 28849081
[TBL] [Abstract][Full Text] [Related]
4. Suppression of Netrin-1 attenuates angiotension II-induced cardiac remodeling through the PKC/MAPK signaling pathway.
Wu G; Wang Z; Shan P; Huang S; Lin S; Huang W; Huang Z
Biomed Pharmacother; 2020 Oct; 130():110495. PubMed ID: 32688140
[TBL] [Abstract][Full Text] [Related]
5. Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro.
Aoki H; Richmond M; Izumo S; Sadoshima J
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):275-84. PubMed ID: 10727428
[TBL] [Abstract][Full Text] [Related]
6. Decreased KCNE2 Expression Participates in the Development of Cardiac Hypertrophy by Regulation of Calcineurin-NFAT (Nuclear Factor of Activated T Cells) and Mitogen-Activated Protein Kinase Pathways.
Liu W; Deng J; Ding W; Wang G; Shen Y; Zheng J; Zhang X; Luo Y; Lv C; Wang Y; Chen L; Yan D; Boudreau RL; Song LS; Liu J
Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611128
[TBL] [Abstract][Full Text] [Related]
7. CD38 promotes angiotensin II-induced cardiac hypertrophy.
Guan XH; Hong X; Zhao N; Liu XH; Xiao YF; Chen TT; Deng LB; Wang XL; Wang JB; Ji GJ; Fu M; Deng KY; Xin HB
J Cell Mol Med; 2017 Aug; 21(8):1492-1502. PubMed ID: 28296029
[TBL] [Abstract][Full Text] [Related]
8. Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway.
Yin Z; Wang X; Zhang L; Zhou H; Wei L; Dong X
Cardiovasc Ther; 2016 Feb; 34(1):21-9. PubMed ID: 26506219
[TBL] [Abstract][Full Text] [Related]
9. Caveolin-3 Overexpression Attenuates Cardiac Hypertrophy via Inhibition of T-type Ca2+ Current Modulated by Protein Kinase Cα in Cardiomyocytes.
Markandeya YS; Phelan LJ; Woon MT; Keefe AM; Reynolds CR; August BK; Hacker TA; Roth DM; Patel HH; Balijepalli RC
J Biol Chem; 2015 Sep; 290(36):22085-100. PubMed ID: 26170457
[TBL] [Abstract][Full Text] [Related]
10. Cooperative Binding of ETS2 and NFAT Links Erk1/2 and Calcineurin Signaling in the Pathogenesis of Cardiac Hypertrophy.
Luo Y; Jiang N; May HI; Luo X; Ferdous A; Schiattarella GG; Chen G; Li Q; Li C; Rothermel BA; Jiang D; Lavandero S; Gillette TG; Hill JA
Circulation; 2021 Jul; 144(1):34-51. PubMed ID: 33821668
[TBL] [Abstract][Full Text] [Related]
11. Telmisartan suppresses cardiac hypertrophy by inhibiting cardiomyocyte apoptosis via the NFAT/ANP/BNP signaling pathway.
Li X; Lan Y; Wang Y; Nie M; Lu Y; Zhao E
Mol Med Rep; 2017 May; 15(5):2574-2582. PubMed ID: 28447738
[TBL] [Abstract][Full Text] [Related]
12. Myogenin suppresses apoptosis induced by angiotensin II in human induced pluripotent stem cell-derived cardiomyocytes.
Gao Q; Wang P; Qiu H; Qiu B; Yi W; Tu W; Lin B; Sun D; Zeng R; Huang M; Chen J; Cen J; Zhuang J
Biochem Biophys Res Commun; 2021 May; 552():84-90. PubMed ID: 33743352
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II and norepinephrine activate specific calcineurin-dependent NFAT transcription factor isoforms in cardiomyocytes.
Lunde IG; Kvaløy H; Austbø B; Christensen G; Carlson CR
J Appl Physiol (1985); 2011 Nov; 111(5):1278-89. PubMed ID: 21474694
[TBL] [Abstract][Full Text] [Related]
14. A critical role of cardiac fibroblast-derived exosomes in activating renin angiotensin system in cardiomyocytes.
Lyu L; Wang H; Li B; Qin Q; Qi L; Nagarkatti M; Nagarkatti P; Janicki JS; Wang XL; Cui T
J Mol Cell Cardiol; 2015 Dec; 89(Pt B):268-79. PubMed ID: 26497614
[TBL] [Abstract][Full Text] [Related]
15. TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy.
Onohara N; Nishida M; Inoue R; Kobayashi H; Sumimoto H; Sato Y; Mori Y; Nagao T; Kurose H
EMBO J; 2006 Nov; 25(22):5305-16. PubMed ID: 17082763
[TBL] [Abstract][Full Text] [Related]
16. Evodiamine Inhibits Angiotensin II-Induced Rat Cardiomyocyte Hypertrophy.
He N; Gong QH; Zhang F; Zhang JY; Lin SX; Hou HH; Wu Q; Sun AS
Chin J Integr Med; 2018 May; 24(5):359-365. PubMed ID: 28875323
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin Upregulates MiR-133a in Cardiac Hypertrophy through AMPK Activation and Reduced ERK1/2 Phosphorylation.
Li Y; Cai X; Guan Y; Wang L; Wang S; Li Y; Fu Y; Gao X; Su G
PLoS One; 2016; 11(2):e0148482. PubMed ID: 26845040
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated overexpression and stimulation of the human angiotensin II type 2 receptor in porcine cardiac fibroblasts does not modulate proliferation, collagen I mRNA expression and ERK1/ERK2 activity, but inhibits protein tyrosine phosphatases.
Warnecke C; Kaup D; Marienfeld U; Poller W; Yankah C; Gräfe M; Fleck E; Regitz-Zagrosek V
J Mol Med (Berl); 2001 Sep; 79(9):510-21. PubMed ID: 11692164
[TBL] [Abstract][Full Text] [Related]
19. Choline inhibits angiotensin II-induced cardiac hypertrophy by intracellular calcium signal and p38 MAPK pathway.
Wang S; Han HM; Pan ZW; Hang PZ; Sun LH; Jiang YN; Song HX; Du ZM; Liu Y
Naunyn Schmiedebergs Arch Pharmacol; 2012 Aug; 385(8):823-31. PubMed ID: 22569796
[TBL] [Abstract][Full Text] [Related]
20. 3,3'-Diindolylmethane attenuates cardiac H9c2 cell hypertrophy through 5'-adenosine monophosphate-activated protein kinase-α.
Zong J; Wu QQ; Zhou H; Zhang JY; Yuan Y; Bian ZY; Deng W; Dai J; Li FF; Xu M; Fang Y; Tang QZ
Mol Med Rep; 2015 Jul; 12(1):1247-52. PubMed ID: 25816057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
